Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Smartwatch detection of atrial fibrillation after thoracic (lung) surgery

Official title: Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

Run by Centre Hospitalier Universitaire, Amiens · NCT06724718 · Data updated 2026-11-12

This test sees if a smartwatch's single-lead ECG can find atrial fibrillation early in adults who recently had major thoracic surgery (lobectomy or pneumonectomy).

More Thoracic Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment302 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedJune 12, 2025
Trial IDNCT06724718 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who had a lobectomy or pneumonectomy with one-lung ventilation within the past 48 hours, are admitted to a conventional surgical unit, can perform a single-lead ECG with a smartwatch, and can give informed consent.

Probably not a fit

Patients with a prior history of atrial fibrillation, pacemaker dependency, need for continuous telemetry for AV block or high-rate arrhythmias, those who had other types of thoracic or chest wall surgery, people who are pregnant, or those under legal guardianship are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Postoperative atrial fibrillation occurs in about 20% of patients after thoracic surgery and can lead to stroke, heart failure, myocardial infarction, and higher mortality if not detected early. This interventional protocol enrolls adults who underwent major thoracic surgery with one-lung ventilation within the past 48 hours and are admitted to a conventional surgical unit. Participants will use a smartwatch capable of single-lead ECG recordings for rhythm monitoring while routine postoperative care continues, and smartwatch-detected events will be compared with standard monitoring and clinical diagnosis. Primary outcomes include detection of POAF and timing of detection, with secondary outcomes addressing subsequent interventions and short-term cardiovascular prognosis.

Why it matters

Potential benefit: If successful, the smartwatch approach could enable earlier AF detection after thoracic surgery, allowing faster treatment to reduce stroke and other complications.

How similar studies have gone: Previous outpatient and ambulatory studies have shown single-lead smartwatch ECGs can detect atrial fibrillation, but their use specifically for immediate postoperative detection after thoracic surgery is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (\>18 years old).
* Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
* Scheduled pneumonectomy or lobectomy.
* Admission to a conventional surgical unit postoperatively.
* Ability to perform single-lead ECG using a smartwatch.
* Coverage under a social security system.
* Signed informed consent

Exclusion Criteria:

* History of atrial fibrillation.
* Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
* Dependency on a pacemaker.
* Participation in another interventional clinical trial affecting POAF incidence.
* Mediastinal, pleural, or chest wall surgery.
* Reoperations or surgeries performed more than 48 hours prior.
* Pregnant women.
* Patients under guardians or similar legal protection.

Where it's running

  • Centre hospitalier Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.